Navigation

Appraisals in development

This table lists NICE technology appraisals. The list can be sorted by title (alphabetically), wave number, anticipated publication date and process. You can also click the appraisal title for full details, or click a column heading to sort the list by that column.

Appraisals in development

Results 101-120 of 152

Title Anticipated publication date Referral date Process
Multiple sclerosis (relapsing-remitting) - laquinimod [ID560] Oct 2014 STA
Multiple sclerosis - cladribine [ID64] TBC Nov 2008 STA
Multiple sclerosis - sativex [ID387] TBC May 2002 MTA
Myelodysplastic syndrome (deletion 5q) - lenalidomide [ID480] TBC Jul 2011 STA
Obesity - lorcaserin [ID337] TBC Jun 2010 STA
Obesity - phentermine (with topiramate) [ID543] TBC Jul 2012 STA
Organ rejection (liver transplantation, prevention) - everolimus [ID559] Jul 2014 STA
Osteoarthritis - diacerein [ID332] TBC Mar 2010 MTA
Osteoarthritis - naproxcinod [ID417] TBC Nov 2010 STA
Osteoarthritis and rheumatoid arthritis - cox-II inhibitors (review) [ID388] TBC MTA
Ovarian (epithelial), fallopian and peritoneal cancer - pazopanib (maintenance) [ID545] TBC Oct 2013 STA
Ovarian cancer - topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for advanced recurrent disease only (Review of TA 91 & TA 222) [ID468] TBC MTA
Ovarian cancer - vintafolide (with pegylated liposomal doxorubicin) [ID564] TBC STA
Pancreatic adenocarcinoma (untreated, metastatic) - paclitaxel albumin-bound nanoparticles (with gemcitabine) [ID680] Jan 2015 Dec 2013 STA
Pancreatic cancer (locally advanced, metastatic) - masitinib [ID566] TBC STA
Pancreatic cancer (metastatic) - nimotuzumab (1st line) [ID513] Aug 2015 STA
Pancreatic cancer - capectitabine [ID389] TBC Dec 2007 STA
Primary (heterozygous-familial and non-familial) hypercholesterolaemia - ezetimibe (review of TA132) [ID627] Jan 2016 MTA
Prostate cancer (advanced, hormone dependent) - degarelix depot [ID590] May 2014 STA
Prostate cancer (hormone refractory) - atrasentan [ID390] TBC Jun 2004 STA

This page was last updated: 17 April 2014

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.